Paris - Delayed Quote EUR

Safe Orthopaedics SA (ALSAF.PA)

Compare
0.0149
+0.0007
+(4.93%)
At close: 2:14:02 PM GMT+1
Loading Chart for ALSAF.PA
DELL
  • Previous Close 0.0142
  • Open 0.0155
  • Bid --
  • Ask --
  • Day's Range 0.0149 - 0.0158
  • 52 Week Range 0.0140 - 10.8000
  • Volume 91,768
  • Avg. Volume 225,534
  • Market Cap (intraday) 132,009
  • Beta (5Y Monthly) 1.03
  • PE Ratio (TTM) --
  • EPS (TTM) -30.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. The company's products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Eragny-sur-Oise, France.

www.safeorthopaedics.com

138

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALSAF.PA

View More

Performance Overview: ALSAF.PA

Trailing total returns as of 2/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALSAF.PA
79.31%
CAC 40
8.49%

1-Year Return

ALSAF.PA
99.85%
CAC 40
4.83%

3-Year Return

ALSAF.PA
100.00%
CAC 40
15.19%

5-Year Return

ALSAF.PA
100.00%
CAC 40
32.62%

Compare To: ALSAF.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALSAF.PA

View More

Valuation Measures

As of 2/5/2025
  • Market Cap

    109.60k

  • Enterprise Value

    199.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    34.37

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -118.84%

  • Return on Assets (ttm)

    -23.74%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.86M

  • Net Income Avi to Common (ttm)

    -6.96M

  • Diluted EPS (ttm)

    -30.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    303k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3.28M

Research Analysis: ALSAF.PA

View More

People Also Watch